Back to the CVE list
CVE-2026-108920

SourceCodester Drug Recommendation System Admin Record Tables user_record.php cross site scripting

CVSS score

5.3

EPSS probability

—

Risk score

0.5

Published

5 h ago

Patch status has not yet been verified

Resmî kaynaklarda yeterli kanıt bulunamadı. Bu sonuç “yama yok” anlamına gelmez.

Impact on My Inventory

Only the personal products you have added to your account are assessed; an organisation's inventory does not appear here.

Checking session…

Vulnerability description

CVE AI research

The stored explanation is shown at once; refreshing evaluates the sources again.

DayBreach AI Explanation

Verified against sources

CVE-2026-108920: SourceCodester Drug Recommendation System Cross-Site Scripting Vulnerability

Sources read

1

Source agreement

Tam uyum

Evidence confidence

%55

Short explanation

A security vulnerability in SourceCodester Drug Recommendation System 1.0 leads to cross-site scripting attacks [S0].

Why does it matter?

This security vulnerability features publicly disclosed exploit information, enabling attackers to execute remote manipulations [S0].

What should be done?

  • Monitor vendor channels for official updates [S0].
  • Follow vendor advisories since the patch status is currently unknown [S0].
Chain of evidence and sources2 verified claims

SourceCodester Drug Recommendation System 1.0 sürümünde siteler arası betik çalıştırma zafiyeti bulunmaktadır.

İstismar halka açık olarak paylaşılmıştır ve uzaktan gerçekleştirilebilir.

Show the technical text from the sources

A security vulnerability has been detected in SourceCodester Drug Recommendation System 1.0. This affects an unknown function of the file Admin/user_record.php of the component Admin Record Tables. Such manipulation of the argument name/email leads to cross site scripting. The attack can be launched remotely. The exploit has been disclosed publicly and may be used.

CVSS vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P

CWE: CWE-79, CWE-94

Explanation produced with the local gemini-flash-lite-latest model. Numerical metrics and the KEV, patch and exploit statuses are not determined by AI.

IMPACT: Affected Products and Software

Affected Products

The following products are affected by CVE-2026-108920 vulnerability. Where our threat engine knows the exact affected versions, they are listed below.

IDVENDORPRODUCTACTION
1SourceCodesterDrug Recommendation System View
Total affected vendors: 1|Products: 1

RED HAT CSAF/VEX: Product Impact Check

Red Hat has not yet published a CSAF/VEX impact record for this CVE. This does not mean “not affected”.

SCORING: CVSS from Multiple Sources

CVSS Scores

The Common Vulnerability Scoring System is a standardised framework for assessing the severity of vulnerabilities in software and systems. We collect and display CVSS scores from several sources for each CVE.

SCOREVERSIONSEVERITYVECTORSOURCE
5.3CVSS V4_0MEDIUMCVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:PCVE CNA
5.0CVSS V2_0—AV:N/AC:L/Au:N/C:N/I:P/A:N/E:POC/RL:ND/RC:URCVE CNA
5.0CVSS V2—AV:N/AC:L/Au:N/C:N/I:P/A:NNVD
4.3CVSS V3_1MEDIUMCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N/E:P/RL:X/RC:RCVE CNA
4.3CVSS V3_0MEDIUMCVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N/E:P/RL:X/RC:RCVE CNA
4.3CVSS V31MEDIUMCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:NNVD
2.1CVSS V40LOWCVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:XNVD

Patch and Remediation Guide

Solution & Remediation Advisory

Patch status unknown

İncelenen resmî kaynaklarda yama durumu doğrulanamadı. Bu sonuç “yama yok” anlamına gelmez.

Confirm the affected product and version against the source evidence above.
Restrict access to internet-facing services and apply network segmentation.
Until a patch is confirmed, follow the vendor advisory; do not read an unknown status as “no patch”.
Monitor server logs and network endpoints for signs of anomalous execution.

Public exploit and active exploitation status

Verified exploit intelligence

No verified public PoC, exploit repository or Metasploit module has been found for this CVE yet.

Weakness Classification and Attack Patterns (CWE & CAPEC)

CWE - Common Weakness Enumeration

While CVE identifies specific instances of vulnerabilities, CWE categorises the common flaws or weaknesses that can lead to vulnerabilities. CVE-2026-108920 is associated with the following CWEs:

Common Attack Pattern Enumeration and Classification (CAPEC)

Common Attack Pattern Enumeration and Classification (CAPEC) stores attack patterns, which are descriptions of the common attributes and approaches employed by adversaries to exploit the CVE-2026-108920 weaknesses.

Attack Vector and Accessibility

ExposureAğ üzerinden
PermissionsGerekmiyor
User—

Official Sources and Advisories

CVSS Vector Radar Chart

5.3 / 10
Attack VectorNetworkComplexityLowPrivilegesNoneUser Interact.RequiredConfidentialityLowIntegrityNoneAvailabilityNone

Vulnerability Scoring Details

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P
Attack VectorNetwork
Attack ComplexityLow
Privileges RequiredNone required
User InteractionP
Confidentiality (Gizlilik)Low
Integrity (Bütünlük)P
Availability (Erişilebilirlik)None

Yama durumu bilinmiyor

İncelenen resmî kaynaklarda yama durumu doğrulanamadı. Bu sonuç “yama yok” anlamına gelmez.

Follow the vendor

Weakness Type (CWE & CAPEC)

Similar Vulnerabilities

Get this vulnerability through the API

Affected products, version ranges, exploitation status and patch information in a single request, with a free key.

curl -H "x-api-key: $DAYBREACH_API_KEY" \
  "https://api.enginteksut.com.tr/api/v1/intel/cves/CVE-2026-108920"
CVE-2026-108920 · SourceCodester Drug Recommendation System Admin Record Tables user_record.php cross site scripting · DayBreach